Sanford Health
Sioux Falls, South Dakota 57117
16 studies enrolling now · 57 studies all time
What they study most
1p36 Deletion Syndrome, 4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome, 4p16.3 Microduplication Syndrome, Achalasia Cardia, Achalasia Icrocephaly Syndrome, Achalasia-Addisonian Syndrome, Achondroplasia, Acquired Ataxia, Acquired Myasthenia Gravis, Acrodysostosis, Addison Disease, Adrenocortical Carcinoma
Studies at this site
- BOOM-IBD2 Pivotal Clinical Trial — Recruiting now
- Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer — Recruiting now
- Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study) — Recruiting now
- Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB) — Recruiting now
- Connect for Cancer Prevention Study (Connect) — Recruiting now
- VIrtual STudy in Achondroplasia for the US (VISTA) — Recruiting now
- A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma — Recruiting now
- Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) — Recruiting now
- Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy — Recruiting now
- Ambulatory Long Length URodynamics Evaluation — Recruiting now
- Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer — Recruiting now
- Midwest Birth Outcomes and Indigenous American Pregnancy — Recruiting now
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford — Recruiting now
- HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry — Recruiting now
- A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) — Running, not enrolling
- AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion — Running, not enrolling
- A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions — Running, not enrolling
- Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS) — Running, not enrolling
- Glucose Levels and Outcomes in Women - Mid Pregnancy — Starting soon
- Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen — Running, not enrolling
- Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) — Running, not enrolling
- Maternal Stress and Blood Sugar Metabolization — Running, not enrolling
- A Comprehensive Approach to Head and Neck Cancer Prehabilitation — Running, not enrolling
- Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) — Completed
- Understanding the Long-term Impact of COVID-19 in Adults (RECOVER) — Completed
- Metallosis on Tissues and Serum Metal Levels in Children — Enrolling by invitation
- Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors — Stopped early
- BlueWind RENOVA iStim™ System for the Treatment of OAB — Completed
- Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home — Completed
- Heart Failure Optimization Study — Completed
- Eating, Sleeping, Consoling for Neonatal Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach — Completed
- Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy — Completed
- Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection — Stopped early
- Autoantibodies in Breast Cancer Detection — Stopped early
- Milademetan in Advanced/Metastatic Solid Tumors — Stopped early
- Pre-operative Alcohol Skin Solutions in Fractured Extremities — Completed
- SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC) — Stopped early
- Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) — Running, not enrolling
- Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence — Completed
- Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES) — Completed
- Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors — Status unconfirmed
- KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC — Stopped early
- Evaluation of Implantable Tibial Neuromodulation (TITAN 1) Feasibility Study — Completed
- CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596) — Status unconfirmed
- Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection — Stopped early
- XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients. — Completed
- Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19 — Status unconfirmed
- Exploring Potential Associations Between Rurality and Hopelessness in IHD Patients — Completed
- Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions — Completed
- Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy — Completed